INR 56.64
(1.09%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 34.47 Million | 41.14 Million | 705 Thousand | 14.89 Million | 23.08 Million | 12.88 Million |
Net Income | 24.93 Million | 50.08 Million | 42.08 Million | 26.92 Million | 34.99 Million | 33.99 Million |
Depreciation & Amortization | 2.36 Million | 2.36 Million | 2.17 Million | 2.11 Million | 2.21 Million | 2.51 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 10.97 Million | 7.71 Million | -22.68 Million | 1.1 Million | -221.14 Thousand | -7.1 Million |
Other non-cash items | -12.11 Million | -19.02 Million | -20.87 Million | -15.25 Million | -13.89 Million | -16.51 Million |
Investing Cash Flow | -5.7 Million | -6.19 Million | -17.93 Million | 20.05 Million | -9.15 Million | 11.28 Million |
Investments in PPE | -6.19 Million | -1.56 Million | -5.63 Million | -1.65 Million | -1.16 Million | -807.92 Thousand |
Acquisitions | - | 47 Thousand | 130 Thousand | 19 Thousand | - | -25.47 Million |
Investment purchases | - | -9 Million | -53.5 Million | -253.00 | -12 Million | -20 Million |
Sales/Maturities of investments | 492 Thousand | 629 Thousand | 36.21 Million | 17.61 Million | - | 28.78 Million |
Other Investing Activities | 5.72 Million | 3.7 Million | 4.85 Million | 4.07 Million | 4.01 Million | 28.78 Million |
Financing Cash Flow | -21.75 Million | -21.75 Million | -21.75 Million | -10.87 Million | -13.11 Million | -13.11 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -21.75 Million | -21.75 Million | -21.75 Million | -10.87 Million | -13.11 Million | -13.11 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | 12.36 Million | 8.67 Million | -23.12 Million | -1.49 Million | 531.47 Thousand | -3.34 Million |
Accounts payables | 676 Thousand | 19 Thousand | -545 Thousand | -717.13 Thousand | 74.06 Thousand | -5.19 Million |
Inventory | - | - | - | 296.00 | - | - |
Other working capital | -2.06 Million | -983 Thousand | 989 Thousand | 3.31 Million | -826.68 Thousand | 1.43 Million |
Cash at beginning of period | 68.92 Million | 51.06 Million | 83.53 Million | 54.59 Million | 52.82 Million | 40.7 Million |
Cash at end of period | 79.78 Million | 66.87 Million | 51.06 Million | 83.53 Million | 54.59 Million | 52.82 Million |
Capital Expenditure | -6.19 Million | -1.56 Million | -5.63 Million | -1.65 Million | -1.16 Million | -807.92 Thousand |
Effect of forex changes on cash | 510 Thousand | 1.91 Million | 570 Thousand | -595 Thousand | 950.6 Thousand | 1.06 Million |
Net cash flow / Change in cash | 10.85 Million | 15.81 Million | -32.47 Million | 28.94 Million | 1.76 Million | 12.12 Million |
Free Cash Flow | 28.27 Million | 39.57 Million | -4.93 Million | 13.24 Million | 21.91 Million | 12.08 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 6.77 Million | 5.65 Million | 24.93 Million | 8.09 Million | 5.65 Million | 5.52 Million |
Depreciation & Amortization | - | - | 2.36 Million | 532 Thousand | 570 Thousand | 555 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 10.97 Million | - | - | - |
Other non-cash items | -6.77 Million | -5.65 Million | -12.11 Million | -8.09 Million | -5.65 Million | -5.52 Million |
Investing Cash Flow | - | - | -5.7 Million | - | - | - |
Investments in PPE | - | - | -6.19 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 492 Thousand | - | - | - |
Other Investing Activities | - | - | 5.72 Million | - | - | - |
Financing Cash Flow | - | - | -21.75 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | -21.75 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | 12.36 Million | - | - | - |
Accounts payables | - | - | 676 Thousand | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -2.06 Million | - | - | - |
Cash at beginning of period | - | - | 68.92 Million | 97.08 Million | 91.42 Million | 68.92 Million |
Cash at end of period | - | - | 79.78 Million | 8.09 Million | 97.08 Million | 5.52 Million |
Capital Expenditure | - | - | -6.19 Million | - | - | - |
Effect of forex changes on cash | - | - | 510 Thousand | - | - | - |
Net cash flow / Change in cash | - | - | 10.85 Million | -88.98 Million | 5.65 Million | -63.4 Million |
Free Cash Flow | - | - | 28.27 Million | 8.09 Million | 5.65 Million | 5.52 Million |
BVNNF
ARTEMISMED
AUMC
5904
002378
MASN